Versant Capital Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-166
Closed -$807 2657
2025
Q1
$807 Hold
166
﹤0.01% 2381
2024
Q4
$1.59K Hold
166
﹤0.01% 2102
2024
Q3
$1.39K Hold
166
﹤0.01% 1666
2024
Q2
$1.13K Hold
166
﹤0.01% 1645
2024
Q1
$420 Hold
166
﹤0.01% 1736
2023
Q4
$398 Sell
166
-142
-46% -$340 ﹤0.01% 1728
2023
Q3
$1.05K Hold
308
﹤0.01% 1511
2023
Q2
$2.26K Sell
308
-68
-18% -$500 ﹤0.01% 1330
2023
Q1
$3.87K Sell
376
-280
-43% -$2.88K ﹤0.01% 1041
2022
Q4
$7.75K Buy
656
+503
+329% +$5.94K ﹤0.01% 746
2022
Q3
$3K Buy
153
+5
+3% +$98 ﹤0.01% 971
2022
Q2
$5K Sell
148
-21
-12% -$709 ﹤0.01% 847
2022
Q1
$7K Buy
+169
New +$7K ﹤0.01% 776
2020
Q3
Sell
-414
Closed -$32K 1346
2020
Q2
$32K Buy
414
+5
+1% +$386 0.01% 292
2020
Q1
$23K Buy
409
+131
+47% +$7.37K 0.01% 327
2019
Q4
$14K Buy
278
+46
+20% +$2.32K 0.01% 577
2019
Q3
$12K Buy
232
+117
+102% +$6.05K 0.01% 635
2019
Q2
$5K Sell
115
-169
-60% -$7.35K ﹤0.01% 953
2019
Q1
$14K Buy
284
+3
+1% +$148 0.01% 772
2018
Q4
$16K Sell
281
-2
-0.7% -$114 0.01% 629
2018
Q3
$18K Sell
283
-44
-13% -$2.8K 0.01% 686
2018
Q2
$16K Hold
327
0.01% 713
2018
Q1
$17K Sell
327
-24
-7% -$1.25K 0.01% 693
2017
Q4
$16K Buy
351
+4
+1% +$182 0.01% 736
2017
Q3
$14K Buy
347
+17
+5% +$686 0.01% 709
2017
Q2
$11K Buy
330
+74
+29% +$2.47K 0.01% 823
2017
Q1
$7K Buy
256
+9
+4% +$246 ﹤0.01% 948
2016
Q4
$8K Sell
247
-23
-9% -$745 ﹤0.01% 892
2016
Q3
$8K Hold
270
﹤0.01% 873
2016
Q2
$7K Sell
270
-2
-0.7% -$52 ﹤0.01% 883
2016
Q1
$9K Sell
272
-42
-13% -$1.39K 0.01% 783
2015
Q4
$12K Buy
+314
New +$12K 0.01% 675